Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer

Optimizing the currently available treatment options for pancreatic cancer (PC) is a priority. Cabazitaxel (CTX), a semisynthetic taxane, is mainly used for treating patients with PC who are resistant to paclitaxel (PTX) or docetaxel, due its poor affinity for P-glycoprotein. However, there are only...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zequn, Xuan, Zefeng, Chen, Jian, Song, Wenfeng, Zhang, Shiyu, Jin, Cheng, Zhou, Mengqiao, Zheng, Shusen, Song, Penghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252454/
https://www.ncbi.nlm.nih.gov/pubmed/32377719
http://dx.doi.org/10.3892/ijo.2020.5053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252454/
https://www.ncbi.nlm.nih.gov/pubmed/32377719
http://dx.doi.org/10.3892/ijo.2020.5053

Ejemplares similares